John Lothian News interviewed Michael Riddle, CEO of Eris Innovations, and Agha Mirza, managing director and global head of rates and OTC products for the CME Group about the success of the Eris SOFR products trading on the CME.
JLN asked about the origin story of the Eris products and when they began to trade on the CME.
We asked about the recent events that have driven the growth of the products. We asked about the impact of the regional banking crisis on the products.
Riddle and Mirza also discussed who the users of the products are and what plans Eris Innovations has to extend the product mix in the next three to five years.
ErisX CEO Tom Chippas is a member of the CFTC’s Technology Advisory Committee (“TAC”) and its cryptocurrency subcommittee. At the latest TAC meeting on...
Last Friday John Lothian News interviewed ICE Chief Development Officer Chris Edmonds about the commentary he wrote that JLN published and why he wrote...
The fintech landscape has seen a remarkable evolution over the past decades, marked by technological advancements and regulatory changes. That progress and those obstacles...
